Phase II Gleevec Idiopathic Hypereosinophilic Syndrome

Clinical trial NCT00230334 · TERMINATED

Trial details

NCT number: NCT00230334
Sponsor: Steven E. Coutre
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Eosinophilia Hypereosinophilic Syndrome

Start date: 2003-06-12
Primary completion: 2006-12-29
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.